2024/03/30 更新

写真a

スミヨシ タカアキ
住吉 孝明
SUMIYOSHI,Takaaki
所属
化学生命工学部 教授
職名
教授
連絡先
メールアドレス
外部リンク

学位

  • 博士(薬学) ( 2005年3月 )

研究分野

  • ナノテク・材料 / 有機合成化学

  • ライフサイエンス / 神経科学一般

  • ライフサイエンス / 薬系化学、創薬科学

  • ライフサイエンス / 生体医工学

学歴

  • 京都大学   薬学研究科   創薬化学専攻

    - 2005年

      詳細を見る

  • 京都大学   薬学部   薬学科

    - 1999年

      詳細を見る

    国名: 日本国

    researchmap

  • 京都大学   薬学研究科   創薬化学専攻

    2001年

      詳細を見る

    国名: 日本国

    researchmap

  • 京都大学   薬学研究科   創薬化学専攻

    2005年

      詳細を見る

    国名: 日本国

    researchmap

経歴

  • 大日本住友製薬株式会社 先端創薬研究所 主任研究員

    2013年4月 - 2014年3月

      詳細を見る

  • 大日本住友製薬株式会社 化学研究所 主任研究員

    2010年7月 - 2013年3月

      詳細を見る

  • 大日本住友製薬株式会社 化学研究所

    2005年10月 - 2010年6月

      詳細を見る

  • 大日本製薬株式会社 化学研究所

    2005年4月 - 2005年9月

      詳細を見る

所属学協会

  • 健康食品管理士会

    2015年4月 - 2017年3月

      詳細を見る

  • 日本薬学会

    2013年4月 - 2016年3月

      詳細を見る

  • 日本薬学会 医薬化学部会

      詳細を見る

  • 薬物動態学会

      詳細を見る

委員歴

  • 近畿支部 副支部長  

    2015年4月 - 2017年3月   

      詳細を見る

  • 学術誌編集委員  

    2013年4月 - 2016年3月   

      詳細を見る

  • Editor  

    2013年4月 - 2016年3月   

      詳細を見る

論文

  • MDMX elevation by a novel Mdmx-p53 interaction inhibitor mitigates neuronal damage after ischemic stroke. 国際誌

    Haomin Yan, Tsutomu Sasaki, Hideaki Kanki, Yoshiyuki Hirata, Kumiko Nishiyama, Sunao Hisada, Shigenobu Matsumura, Yasuo Nagaoka, Takaaki Sumiyoshi, Seiichi Nagano, Akiko Nakata, Minoru Yoshida, Shinichi Uesato, Hideki Mochizuki

    Scientific reports   12 ( 1 )   21110 - 21110   2022年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mdmx and Mdm2 are two major suppressor factors for the tumor suppressor gene p53. In central nervous system, Mdmx suppresses the transcriptional activity of p53 and enhances the binding of Mdm2 to p53 for degradation. But Mdmx dynamics in cerebral infarction remained obscure. Here we investigated the role of Mdmx under ischemic conditions and evaluated the effects of our developed small-molecule Protein-Protein Interaction (PPI) inhibitors, K-181, on Mdmx-p53 interactions in vivo and in vitro. We found ischemic stroke decreased Mdmx expression with increased phosphorylation of Mdmx Serine 367, while Mdmx overexpression by AAV-Mdmx showed a neuroprotective effect on neurons. The PPI inhibitor, K-181 attenuated the neurological deficits by increasing Mdmx expression in post-stroke mice brain. Additionally, K-181 selectively inhibited HDAC6 activity and enhanced tubulin acetylation. Our findings clarified the dynamics of Mdmx in cerebral ischemia and provide a clue for the future pharmaceutic development of ischemic stroke.

    DOI: 10.1038/s41598-022-25427-4

    PubMed

    researchmap

  • Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier 査読

    KUROSAWA, Toshiki, TEGA, Yuma, UCHIDA, Yasuo, HIGUCHI, Kei, TABATA, Hidetsugu, SUMIYOSHI,Takaaki, KUBO, Yoshiyuki, TERASAKI, Tetsuya, DEGUCHI, Yoshiharu

    Pharmaceutics   14(8), 1683 ( 8 )   1683 - 1683   2022年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    A proton-coupled organic cation (H+/OC) antiporter working at the blood–brain barrier (BBB) in humans and rodents is thought to be a promising candidate for the efficient delivery of cationic drugs to the brain. Therefore, it is important to identify the molecular entity that exhibits this activity. Here, for this purpose, we established the Proteomics-based Identification of transporter by Crosslinking substrate in Keyhole (PICK) method, which combines photo-affinity labeling with comprehensive proteomics analysis using SWATH-MS. Using preselected criteria, the PICK method generated sixteen candidate proteins. From these, knockdown screening in hCMEC/D3 cells, an in vitro BBB model, identified two proteins, TM7SF3 and LHFPL6, as candidates for the H+/OC antiporter. We synthesized a novel H+/OC antiporter substrate for functional analysis of TM7SF3 and LHFPL6 in hCMEC/D3 cells and HEK293 cells. The results suggested that both TM7SF3 and LHFPL6 are components of the H+/OC antiporter.

    DOI: 10.3390/pharmaceutics14081683

    researchmap

  • Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 Inhibitors

    Kosuke Hashimoto, Soichiro Ide, Mayumi Arata, Akiko Nakata, Akihiro Ito, Takashi K. Ito, Norio Kudo, Bangzhong Lin, Kazuto Nunomura, Keiko Tsuganezawa, Minoru Yoshida, Yasuo Nagaoka, Takaaki Sumiyoshi

    ACS Medicinal Chemistry Letters   2022年6月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:American Chemical Society (ACS)  

    DOI: 10.1021/acsmedchemlett.2c00081

    researchmap

  • GPR91 antagonist and TGF-β inhibitor suppressed collagen production of high glucose and succinate induced HSC activation 査読

    Sakai, Mutsuko, Sumiyoshi, Takaaki, Aoyama, Takuya, Urayama, Kenji, Yoshimura, Ryoichi

    Biochem. Biophys. Res. Commun.   2020, 530, 362–366.   2020年8月

     詳細を見る

  • A novel piperidine degradation mechanism in a newly isolated piperidine degrader Pseudomonas sp. strain KU-43P 査読

    Yamamoto, Taisei, Liu, Yaxuan, Sumiyoshi, Takaaki, Hasegawa, Yoshie, Iwaki, Hiroaki

    J. Gen. Appl. Microbiol.   2020, 66, 265-272. ( 5 )   265 - 272   2020年7月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.2323/jgam.2019.11.006

    researchmap

  • Identification and Quantification of Short-Chain Aldehydes Generated from Hair by Ultraviolet Ray Irradiation 査読

    Horibe, Ippei, Kitayama, Shintaro, Nagai, Mizuki, Kokuwano, Yuri, Nakai, Ayaka, SUMIYOSHI, Takaaki, NAGAOKA, Yasuo

    J. Soc. Cosmet. Chem. Jpn.   2020, 54, 169–176.   2020年6月

     詳細を見る

  • Design, Synthesis and Structure-Activity Relationship Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors 査読

    Seiya Hiranaka, Mayumi Arata, Akiko Nakata, Akiko Tanaka, Yoshinobu Hashizume, Norio Kudo, Akihiro Ito, Minoru Yoshida, Shinichi Uesato, Yasuo Nagaoka, Takaaki Sumiyoshi

    Design, Synthesis and Structure-Activity Relationship Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors   101 ( 2 )   726 - 737   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    researchmap

  • Nano-Honeycomb Electrode-based QCM Sensor and Its Application for PPI Detection 査読

    Naoto Asai, Naohiro Matsumoto, Nozomi Kazama, Yasuo Nagaoka, Takaaki Sumiyoshi, Tomohiro Shimizu, Shoso Shingubara, Takeshi Ito

    IEEE Sensors Journal   2019, 19, 4025-4030.   2019年2月

     詳細を見る

  • Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds 査読

    夏谷 格, 岩田吏世, 山井悠介, 石田恭次, 長岡康夫, 住吉孝明

    Chemical Biology & Drug Design   2019, 93, 657-665.   2019年2月

     詳細を見る

    Drug design using boron‐containing heterocycles has attracted a great deal of attention because these compounds are believed to possess high biological activity. However, information on the synthetic methodology and pharmacokinetic profiling of boron‐containing compounds is limited. In this study, we provide a new synthetic route for preparation of spiro‐fused benzoxaborin derivatives and investigate their in vitro pharmacokinetic properties. Our efforts led to the successful construction of a chemical library of spiro‐fused benzoxaborin derivatives with appropriate physicochemical and in vitro pharmacokinetic properties for oral drugs. These results indicate that the synthesized boron‐containing compounds are therefore eligible for classification in a novel chemical library.

    DOI: 10.1111/cbdd.13496

    researchmap

  • Asymmetric Synthesis of t-Butyl 3-Alkyl-oxindole-3-carboxylates via Chiral Phosphoric Acid-Catalyzed Desymmetrization of Di-t-butyl 2-Alkyl-2-(2-aminophenyl)malonates

    Kyoji Ishida, Masahiro Shimizu, Yusuke Yamai, Itaru Natsutani, Shinichi Uesato, Yasuo Nagaoka, Takaaki Sumiyoshi

    Heterocycles   99(2), 1398 -1411   2019年2月

     詳細を見る

  • SYNTHESIS OF SUBSTITUTED t-BUTYL 3-ALKYLOXINDOLE-3-CARBOXYLATES FROM DI-t-BUTYL (2-NITROPHENYL)MALONATES

    Yu-suke Yamai, Akio Tanaka, Tatsuo Yajima, Kyoji Ishida, Itaru Natsutani, Shinichi Uesato, Yasuo Nagaoka, Takaaki Sumiyoshi

    HETEROCYCLES   97 ( 1 )   192 - 210   2018年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Using a novel tandem reduction-cyclization, we synthesized t-butyl 3-alkyloxindole-3-carboxylates from the di-t-butyl 2-alkyl-2-(2-nitrophenyl)malonate. Introduction of an alpha-substituent to the di-t-butyl 2-(2-nitrophenyl)-malonates and addition of acid promoted reactivity. This methodology was successfully applied to gram-scale-synthesis of the t-butyl 3-methyloxindole-3-carboxylate 1 and 3-hydroxyrnethy1-3-methyloxindole 2 without silica gel column chromatography.

    DOI: 10.3987/COM-17-S(T)2

    Web of Science

    researchmap

  • Design, Synthesis, and Blood–Brain Barrier Transport Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors 査読 国際誌

    Seiya Hiranaka, Yuma Tega, Kei Higuchi, Toshiki Kurosawa, Yoshiharu Deguchi, Mayumi Arata, Akihiro Ito, Minoru Yoshida, Yasuo Nagaoka, Takaaki Sumiyoshi

    ACS Med. Chem. Lett.   2018, 9, 884–888. ( 9 )   884 - 888   2018年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1021/acsmedchemlett.8b00099

    PubMed

    researchmap

  • Efficient Synthesis of t-Butyl 3-Alkyl-N-hydroxyoxindole-3-carboxylates from Di-t-butyl 2-nitrophenylmalonates 査読

    Yu-suke Yamai, Kyoji Ishida, Itaru Natsutani, Shinichi Uesato, Yasuo Nagaoka, Takaaki Suiyoshi

    Heterocycles   2018, 97, 1257–1268.   2018年5月

     詳細を見る

  • Synthesis of Substituted t-Butyl 3-Alkyl-oxindole-3-carboxylates from Di-t-Butyl (2-Nitrophenyl)malonates 査読

    YAMAI, Yu-suke, TANAKA, Akio, YAJIMA, Tatsuo, ISHIDA. Kyoji, NATSUTANI, Itaru, UESATO, Shinichi, NAGAOKA, Yasuo, SUMIYOSHI, Takaaki

    Heterocycles   2018, 97, 192–210.   2017年12月

     詳細を見る

  • Process Development for the Synthesis of a Selective M-1 and M-4 Muscarinic Acetylcholine Receptors Agonist

    Yoshiharu Uruno, Kazuki Hashimoto, Yoichi Hiyama, Takaaki Sumiyoshi

    ORGANIC PROCESS RESEARCH & DEVELOPMENT   21 ( 10 )   1610 - 1615   2017年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    A practical and chromatography-free synthetic process to selective M-1 and M-4 muscarinic acetylcholine receptors agonist was developed and demonstrated on a several hundred gram scale. The key feature of this route is N,N- dimethylcarbamoylation of the anilinic nitrogen on the spiro 7-azaindoline structure via intermolecular migration of the NjN- dimethylcarbamoyl group. The resulting compound 1 was prepared in 43% overall yield with a chemical purity >99% via six steps starting with (2-chloropyridin-3-yl)acetonitrile.

    DOI: 10.1021/acs.oprd.7b00236

    Web of Science

    researchmap

  • Discovery of new low-molecular-weight p53–Mdmx disruptors and their anti-cancer activities

    Shinichi Uesato, Yoshihiro Matsuura, Saki Matsue, Takaaki Sumiyoshi, Yoshiyuki Hirata, Suzuho Takemoto, Yasuyuki Kawaratani, Yusuke Yamai, Kyoji Ishida, Tsutomu Sasaki, Masato Enari

    Bioorg. Med. Chem.   24 ( 8 )   1919 - 1926   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.bmc.2016.03.021

    Web of Science

    researchmap

  • Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M-1 and M-4 muscarinic acetylcholine receptors agonists

    Yoshiharu Uruno, Yasuko Konishi, Atsushi Suwa, Kentaro Takai, Kengo Tojo, Tomokazu Nakako, Mutsuko Sakai, Takeshi Enomoto, Harumi Matsuda, Atsushi Kitamura, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   25 ( 22 )   5357 - 5361   2015年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized a series of dihydroquinazolinone derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors agonists. Introduction of the N-carbethoxy piperidine unit into a HTS hit compound followed by optimization of the amine linker and the carbamoyl moiety led to the identification of compound 1 as a potential candidate. The identified compound 1 showed high selectivity for M-1 and M-4 muscarinic acetylcholine receptors with M-4 partial agonistic activity. In addition, compound 1 showed good brain penetration and reversed methamphetamine-induced hyperlocomotion in rats (ED50 = 3.0 mg/kg, sc). (C) 2015 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2015.09.032

    Web of Science

    researchmap

  • A short synthesis of (+)-β-lycorane by asymmetric conjugate addition cascade

    Katsumi Nishimura, Naoshi Fukuyama, Tomohisa Yasuhara, Mitsuaki Yamashita, Takaaki Sumiyoshi, Yasutomo Yamamoto, Ken-ichi Yamada, Kiyoshi Tomioka

    Tetrahedron   71 ( 39 )   7222 - 7226   2015年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.tet.2015.03.014

    Web of Science

    researchmap

  • Cyclic Model for the Asymmetric Conjugate Addition of Organolithiums with Enoates 招待 査読

    Katsumi Nishimura, Naoshi Fukuyama, Mitsuaki Yamashita, Takaaki Sumiyoshi, Yasutomo Yamamoto, Ken-ichi Yamada, Kiyoshi Tomioka

    SYNTHESIS-STUTTGART   47 ( 15 )   2256 - 2264   2015年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:GEORG THIEME VERLAG KG  

    The chiral diether ligand controlled asymmetric conjugate addition of organolithiums to nona-2,7-dienedioates preferentially proceeds via the s-cis conformation with coordination of the carbonyl oxygen atom to the lithium to give a lithium E-enolate intermediate. Subsequent intramolecular conjugate addition of the enolate also proceeds via a cyclic transition state involving the lithium and the s-cis-enoate, resulting in trans,trans-trisubstituted cyclohexanes with high enantiomeric excesses and yields.

    DOI: 10.1055/s-0034-1380702

    Web of Science

    researchmap

  • Cyclic Model for the Asymmetric Conjugate Addition of Organolithiums with Enoates 査読

    Katsumi Nishimura, Naoshi Fukuyama, Mitsuaki Yamashita, Takaaki Sumiyoshi, Yasutomo Yamamoto, Ken-ichi Yamada, Kiyoshi Tomioka

    Synthesis   2015, 47, 2256-2264.   2015年5月

     詳細を見る

  • Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M-4 muscarinic acetylcholine receptor agonists

    Atsushi Suwa, Yasuko Konishi, Yoshiharu Uruno, Kentaro Takai, Tomokazu Nakako, Mutsuko Sakai, Takeshi Enomoto, Yoshiaki Ochi, Harumi Matsuda, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   24 ( 13 )   2909 - 2912   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized novel N-sulfony1-7-azaindoline derivatives as selective M-4 muscarinic acetylcholine receptor agonists. Modification of the N-carbethoxy piperidine moiety of compound 2, an M-4 muscarinic acetylcholine receptor (mAChR)-preferring agonist, led to compound I, a selective M-4 mAChR agonist. Compound 1 showed a highly selective M-4 mAChR agonistic activity with weak hERG inhibition in vitro. A pharmacokinetic study of compound 1 in vivo revealed good bioavailability and brain penetration in rats. Compound 1 reversed methamphetamine-induced locomotor hyperactivity in rats (1-10 mg/kg, po). (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2014.04.083

    Web of Science

    researchmap

  • Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M-1 and M-4 muscarinic acetylcholine receptors selective agonists

    Kentaro Takai, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Yoshiharu Uruno, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Hiroyuki Nishikawa, Gakuji Hashimoto, Takeshi Enomoto, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   24 ( 14 )   3189 - 3193   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized novel N-substituted 7-azaindoline derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors (mAChRs) agonists. Hybridization of compound 2 with the HTS hit compound 5 followed by optimization of the N-substituents of 7-azaindoline led to identification of compound 1, which showed highly selective M-1 and M-4 mAChRs agonistic activity, weak human ether-a-go-go related gene inhibition, and good bioavailability in multiple animal species. (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2014.04.085

    Web of Science

    researchmap

  • Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors

    Motoji Kawasaki, Akira Fusano, Tomohiro Nigo, Shunya Nakamura, Mari N. Ito, Yasuhiro Teranishi, Satoshi Matsumoto, Hiroshi Toda, Naruaki Nomura, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   24 ( 12 )   2689 - 2692   2014年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of 2,3-disubstituted pyridines were synthesized as potential non-emetic PDE4 inhibitors. To decrease brain exposure and minimize emesis, we modified the lipophilic moiety of a series of emetic PDE4 inhibitors and found that introduction of a hydroxy group into the pyridine moiety of the side chain led to non-emetic compounds with preserved PDE4 inhibitory activity. Following optimization at the phenoxy group, we identified compound 1 as a potent non-emetic PDE4 inhibitor. Compound 1 showed significant efficacy in an animal model of asthma without inducing emesis. (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2014.04.052

    Web of Science

    researchmap

  • Syntheses of [C-14]-labeled 2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy] pyridine, a phosphodiesterase 4 inhibitor and its metabolites

    Takeshi Ochi, Yusuke Sawayama, Motoji Kawasaki, Tomohiro Nigo, Masashi Nakao, Tomoki Omodani, Takaaki Sumiyoshi

    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS   57 ( 7 )   477 - 479   2014年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    We describe here the synthesis of [C-14]-2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy] pyridine (1), a phosphodiesterase 4 inhibitor. [C-14]-Labeled 1 was prepared in three steps from [C-14]-2-bromopyridin-3-ol in an overall yield of 32%. Preparation of [C-14]-labeled 2 and 3, two metabolites of 1, is also described.

    DOI: 10.1002/jlcr.3211

    Web of Science

    researchmap

  • Muscarinic acetylcholine receptor activators 査読

    Takaaki Sumiyoshi, Takaaki Sumiyoshi, Takeshi Enomoto, Takeshi Enomoto

    Topics in Medicinal Chemistry   13   183 - 212   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Verlag  

    Modulation of muscarinic acetylcholine receptors (mAChRs) is one of the most attractive therapeutic strategies for the treatment of schizophrenia. Pilot clinical studies of the M1/M4 mAChR-preferring agonist xanomeline as well as animal studies using M1–M5 mAChR knockout mice suggest that selective activation of M1 and/or M4 mAChRs is a key concept in the treatment of psychosis and cognitive deficits in patients with schizophrenia. However, over the past two decades, clinical development of mAChR agonists has not been successful mainly due to these agents’ narrow safety margin caused by the lack of true subtype selectivity. However, recent advances in medicinal chemistry might enable researchers to overcome the hurdles that earlier mAChR agonists failed to pass. Here, we describe recent advances in the development of subtype-selective mAChR activators for treatment of schizophrenia.

    DOI: 10.1007/7355_2014_47

    Scopus

    researchmap

  • Experimental and computational study of intermolecular migration of N,N-dimethylcarbamoyl group from N(7) to N(1) on a 7-azaindoline derivative

    Yoshiharu Uruno, Akio Tanaka, Kazuki Hashimoto, Shinya Usui, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Kentaro Takai, Wataru Katoda, Norio Fujiwara, Takaaki Sumiyoshi

    Tetrahedron   69 ( 46 )   9675 - 9681   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier Ltd  

    N,N-Dimethylcarbamoylation of the anilinic nitrogen atom N(1) on the spiro 7-azaindoline consists of two steps. The first step is N,N- dimethylcarbamoylation of the pyridyl nitrogen atom N(7), leading to the formation of an isolable intermediate. The second step is intermolecular migration of the N,N-dimethylcarbamoyl group from the pyridyl nitrogen atom N(7) to the anilinic nitrogen atom N(1). We accomplished optimization of the reaction conditions based on the revealed reaction mechanism and a large scale synthesis of compound 3 in quantitative yield. © 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tet.2013.09.024

    Scopus

    researchmap

  • Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors

    Yoshihiro Kato, Motoji Kawasaki, Tomohiro Nigo, Shunya Nakamura, Akira Fusano, Yasuhiro Teranishi, Mari N. Ito, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY   21 ( 18 )   5851 - 5854   2013年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of 2,3-disubstituted pyridines were synthesized and evaluated for their PDE4 inhibitory activity. We successfully modified undesirable cyano group of initial lead compound 2 to 4-pyridyl group with improvement of in vitro efficacy and optimized the position of nitrogen atoms in pyridine moiety and alkylene linker. The most potent compound showed significant efficacy in animal models of asthma and inflammation. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2013.07.007

    Web of Science

    researchmap

  • Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M-1 and M-4 muscarinic acetylcholine receptors agonists

    Kentaro Takai, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Yoshiharu Uruno, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Hiroyuki Nishikawa, Gakuji Hashimoto, Takeshi Enomoto, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   23 ( 16 )   4644 - 4647   2013年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    We designed and synthesized N-substituted 8-azatetrahydroquinolone derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors agonists. Optimization of selected derivatives led to the discovery of compound 7 as a highly potent M-1 and M-4 agonist with weak hERG inhibition. Oral administration of compound 7 improved psychosis-like behavior in rats. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2013.06.013

    Web of Science

    researchmap

  • Discovery of novel N-substituted oxindoles as selective M1 and M4 muscarinic acetylcholine receptors partial agonists

    Takaaki Sumiyoshi, Takeshi Enomoto, Kentaro Takai, Yoko Takahashi, Yasuko Konishi, Yoshiharu Uruno, Kengo Tojo, Atsushi Suwa, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi

    ACS Medicinal Chemistry Letters   4 ( 2 )   244 - 248   2013年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Activation of the M1 and M4 muscarinic acetylcholine receptors is thought to play an important role in improving the symptoms of schizophrenia. However, discovery of selective agonists for these receptors has been a challenge, considering the high sequence homology and conservation of the orthosteric acetylcholine binding site among muscarinic acetylcholine receptor subtypes. We report in this study the discovery of novel N-substituted oxindoles as potent muscarinic acetylcholine receptor partial agonists selective for M1 and M4 over M2, M3, and M 5. Among these oxindoles, compound 1 showed high selectivity for the M1 and M4 receptors with remarkable penetration into the central nervous system. Compound 1 reversed methamphetamine- and apomorphine-induced psychosis-like behaviors with low potency to extrapyramidical and peripheral side effects. © 2013 American Chemical Society.

    DOI: 10.1021/ml300372f

    Scopus

    researchmap

  • Asymmetric Synthesis of the Carbon-14-Labeled Selective Glucocorticoid Receptor Modulator using Cinchona Alkaloid Catalyzed Addition of 6-Bromoindole to Ethyl Trifluoropyruvate

    Takaaki Sumiyoshi, Daisuke Urabe, Kengo Tojo, Masato Sakamoto, Kazumi Niidome, Norie Tsuboya, Tomoko Nakajima, Masanori Tobe

    MOLECULES   17 ( 6 )   6507 - 6518   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    We describe in this study the asymmetric synthesis of radioisotope (RI)-labeled selective glucocorticoid receptor modulator. This synthesis is based on optimization of the cinchona alkaloid catalyzed addition of 6-bromoindole to ethyl trifluoropyruvate and Negishi coupling of zinc cyanide to the 6-bromoindole moiety. [C-14] Labeled (-)-{4-[(1-{2-[6-cyano-1-(cyclohexylmethyl)-1H-indol-3-yl]-3,3,3-trifluoro-2-hydroxypropyl} piperidin-4-yl)oxy]-3-methoxyphenyl}acetic acid (-)-1 was synthesized successfully with high enantioselectivity (> 99% ee) and sufficient radiochemical purity.

    DOI: 10.3390/molecules17066507

    Web of Science

    researchmap

  • Asymmetric synthesis of the 6-cyanoindole derivatives as non-steroidal glucocorticoid receptor modulators using (+)- and (-)-tert-butyl 6-cyano-3[3-ethoxy-1,1,1-trifluoro-2-hydroxy-3-oxopropan-2-yl]-1H-indole-1-carboxylate

    Takaaki Sumiyoshi, Kengo Tojo, Daisuke Urabe, Masanori Tobe

    TETRAHEDRON-ASYMMETRY   22 ( 2 )   153 - 160   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    We have successfully synthesized enantiomerically pure (+)- and (-)-tert-butyl 6-cyano-3-[3-ethoxy-1,1,1-trifluoro-2-hydroxy-3-oxopropan-2-yl]-1H-indole-1-carboxylate (+)-1 and (-)-1, which are key intermediates of non-steroidal glucocorticoid receptor modulators, by employing a cinchona alkaloid catalyzed addition of 6-cyanoindole to ethyl trifluoropyruvate. The optimized method can be applied to large-scale synthesis. Furthermore, using the key intermediates (+)-1 and (-)-1, enantiomerically pure glucocorticoid receptor modulators (+)-3 and (-)-3 can be synthesized (>99% ee for both compounds). The glucocorticoid receptor binding affinity was influenced by the stereogenic center at the trifluoromethyl alcohol moiety; compound (-)-3 showed a higher binding affinity compared to (+)-3. (C) 2011 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetasy.2011.01.020

    Web of Science

    researchmap

  • Total Synthesis of (−)-Lycorine and (−)-2-epi-Lycorine by Asymmetric Conjugate Addition Cascade

    Ken-ichi Yamada, Mitsuaki Yamashita, Takaaki Sumiyoshi, Katsumi Nishimura, Kiyoshi Tomioka

    Org. Lett.   11 ( 7 )   1631 - 1633   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1021/ol9003564

    Web of Science

    researchmap

  • 36 有機リチウムの不斉タンデム型共役付加-閉環反応の開発とLycorine類の不斉全合成への展開(口頭発表の部)

    山田 健一, 山下 光明, 西村 克己, 福山 尚志, 住吉 孝明, 富岡 清

    天然有機化合物討論会講演要旨集   ( 49 )   211 - 216   2007年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:天然有機化合物討論会  

    We have been involved in development of asymmetric reactions using diether 2 as a chiral chelating ligand and have succeeded in asymmetric addition of organolithium reagents to α,β-unsaturated carboxylates (Scheme 1). The addition of organolithium reagent to α,β-unsaturated carboxylate gives lithium enolate intermediate, whose intermolecular trapping with another α,β-unsaturated carboxylate moiety would produce highly functionalized chiral cyclohexane building blocks, such as 4 (Scheme 2). We planned asymmetric synthesis of Amaryllidaceae alkaloids, lycorine (1) and related compounds using 4 as a key intermediate. The investigation of the key tandem asymmetric conjugate addition-cyclization reaction using chiral ligand 2 revealed that the bulky ortho-substituent, TMS group of aryllithium 6b using important to achieve the first addition step in high enantioselectivity (Scheme 3). Besides, the ethylenedioxy group of α,β-unsaturated carboxylate 3 improves diastereoselectivity in the cyclization step probably because the replacement of H with O makes 1,3-diaxial interaction more unfavorable in the transition state that gives trans-cis isomers 8 (Figure 2). With enantiomerically enriched cyclohexane 9 in hand, we started the asymmetric synthesis of lycorines (Scheme 4). Treatment of 9 with ethanolic HCl gave carboxylic acid 10, whose Curtius rearrangement gave carbamate 11 in good yield. Formation of the tetracyclic core was achieved via lactam formation and Bishler-Napieralski reaction to give ketone 14. Formal synthesis of 1-deoxylycorine was accomplished via double bond formation by IBX oxidation of silyl enolate and reduction of the resulting enone 15. Introduction of 2-hydroxy functionality to ketone 14 was achieved stereoselectively by Magnus' chemistry (Scheme5). Formation of double bond followed by reduction gave 2-epi-lycorine diacetate (23) after acetylation of the resulting 2-epi-lycorine (22).

    DOI: 10.24496/tennenyuki.49.0_211

    CiNii Books

    researchmap

  • Molecular Assembly of C2-Symmetric Bis-(2S)-2-methyldodecanoylamides of α,ω-Alkylidenediamines into Coiled Coil and Twisted Ribbon Aggregates

    Takaaki Sumiyoshi, Katsumi Nishimura, Minoru Nakano, Tetsuro Handa, Yoshihisa Miwa, Kiyoshi Tomioka

    J. Am. Chem. Soc.   125 ( 40 )   12137 - 12142   2003年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1021/ja035085t

    Web of Science

    researchmap

  • Molecular Assembly and Gelating Behavior of Didodecanoylamides of α,ω-Alkylidenediamines

    Kiyoshi Tomioka, Takaaki Sumiyoshi, Shinobu Narui, Yasuo Nagaoka, Akira Iida, Yoshihisa Miwa, Tooru Taga, Minoru Nakano, Tetsuro Handa

    J. Am. Chem. Soc.   123 ( 47 )   11817 - 11818   2001年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1021/ja0169318

    Web of Science

    researchmap

  • Molecular Assembly and Gelating Behavior of Didodecanoylamides of ┣T00210┫,┣T00360┫-Alkylidenediamides.

    Kiyoshi Tomioka, Takaaki Sumiyoshi, Shinobu Narui, Yasuo Ngaoka, Akira Iida, Yoshihisa Miwa, Tooru Taga, Minoru Nkano, Tetsuro H;a

    J.Am.Che.Soc.   123/47,11817-11818   2001年

     詳細を見る

    科研費基盤研究 200004-200303

    researchmap

▼全件表示

書籍等出版物

  • Current Topics-Recent Progress in Medicinal Chemistry-Foreword

    SUMIYOSHI,Takaaki( 担当: 単著)

    Chemical & Pharmaceutical Bulletin  2018年1月 

  • 多様な大環状化合物の効率的合成法の開発

    住吉 孝明( 担当: 単著)

    理工学と技術  2014年11月 

     詳細を見る

  • Muscarinic Acetylcholine Receptor Activators 査読

    Takaaki Sumiyoshi, Takeshi Enomoto

    Springer Berlin Heidelberg  2014年4月 

     詳細を見る

MISC

  • Drug discovery and large-scale synthesis for 7-azaindoline derivatives as potent, orally available, selective M1 and M4 muscarinic acetylcholine receptors agonists

    Yoshiharu Uruno, Yasunao Inoue, Yasuko Konishi, Atsushi Suwa, Kentaro Takai, Kazuki Hashimoto, Harumi Matsuda, Tomokazu Nakako, Mutsuko Sakai, Gakuji Hashimoto, Takeshi Enomoto, Atsushi Kitamura, Yasuaki Uematsu, Akihiko Kiyoshi, Takaaki Sumiyoshi

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   249   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • Sirtuin 1選択的阻害活性をもつ新規2-hydroxy-1-naphthaldehyde誘導体とその抗がん活性

    瓦谷泰之, 平田佳之, 深田尚文, 住吉孝明, 長岡康夫, 伊藤昭博, 吉田稔, 上里新一

    メディシナルケミストリーシンポジウム講演要旨集   32nd   2014年

     詳細を見る

  • Drug discovery of novel N-substituted oxindoles as potent and high selective muscarinic M-1 and M-4 receptor partial agonist

    Kentaro Takai, Takaaki Sumiyoshi, Yoshiharu Uruno, Kengo Tojo, Atsushi Suwa, Yoko Takahashi, Yasuko Konishi, Takeshi Enomoto, Harumi Matsuda, Mutsuko Sakai, Tomokazu Nakako, Akihiko Kiyoshi, Yasuaki Uematsu, Atsushi Kitamura

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   245   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • Asymmetric synthesis of 6-cyanoindoles as nonsteroidal glucocorticoid receptor modulators

    Takaaki Sumiyoshi, Naoki Chiyo, Kengo Tojo, Daisuke Urabe, Masanori Tobe

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   241   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER CHEMICAL SOC  

    Web of Science

    researchmap

共同研究・競争的資金等の研究課題

  • 中枢移行性ヒストン脱アセチル化酵素阻害剤の探索研究

    研究課題/領域番号:19K07008  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    住吉 孝明

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    中枢性ヒストンデアセチラーゼ(HDAC)阻害剤は、アルツハイマー病、パーキンソン病などの神経変性疾患やうつ病などの精神疾患の新規作用機序に基づく治療薬として期待されている。しかしながら、既知のHDAC阻害剤の多くは中枢移行性が低く、精神神経疾患治療薬として承認されたHDAC阻害剤は現状存在しない。HDAC阻害剤の低い中枢移行性を向上させるため、一般的に中枢移行性が高いヒスタミン受容体拮抗薬の構造を導入した化合物の設計・合成・評価を行った。その結果、高い阻害活性と中枢移行性を併せもつHDAC阻害剤を見出した。特にKH-259はマウス尾懸垂試験で高い抗うつ活性を示した。

    researchmap

  • ムスカリン受容体部分作動薬の探索研究

    研究課題/領域番号:15K18903  2015年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業  若手研究(B)

    住吉 孝明, 中村 有沙, 南原 拓弥, 村上 将登

      詳細を見る

    配分額:4030000円 ( 直接経費:3100000円 、 間接経費:930000円 )

    ムスカリン受容体は副交感神経を活性化する神経伝達物質アセチルコリンの受容体である。ムスカリン受容体にはM1-M5の5つのサブタイプがあり、M1受容体の活性化が認知機能を向上させる効果がある。本研究は、作動性と拮抗性を併せ持ち、適度にM1受容体を活性化する部分作動薬を創製し、副作用を低減した新たな精神神経疾患治療薬になりうる化合物を見出すことを目的とする。
    M1受容体およびM4受容体の両方を作動する化合物の構造を種々変換した結果、ムスカリンM1受容体選択的部分作動性を示す化合物を見出した。これらの化合物はアルツハイマー病等の精神神経疾患の改善薬への応用が期待できる。

    researchmap